Inflammation: Key lessons for what you can and cannot say (and when and how to say it)
The understanding of how nutrition and diet can influence inflammation is deepening. Several years ago it was touted as the next big thing for nutrition and nutraceuticals, but regulatory constraints have stifled what can be said about the potential benefits. ‘Inflammation’ is not forbidden in structure-function claims, however, but you have to choose the wording carefully.
In this forum, NutraIngredients-USA will look at the role of chronic inflammation in every day health, the key anti-inflammatory nutrients and ingredients, the science to support the potential, the legal considerations for marketing such products, and how best to communicate these benefits to consumers.
NutraIngredients-USA’s Inflammation: Opportunities and Challenges Forum will air on November 19. Joining Hank Schultz for the hour long discussion are:
Ann Skulas-Ray, PhD, Research Associate, Penn State University: As a research associate at Penn State Univeristy, Dr Skulas-Ray has researched how polyunsaturated fatty acids, plant-derived compounds, and other agents can be used to attenuate excessive inflammation. She has also looked into how sleep quality, physical activity, and psychosocial parameters affect inflammation and its resolution.
Justin Prochnow, Shareholder, Greenberg Traurig LLP: A shareholder in the law firm Greenberg Traurig LLP, Prochnow focuses on regulatory and business issues in the food, medical device, drug and cosmetic industries. Prochnow works with dietary supplement, sports nutrition, beverage, conventional food companies deal with the Food and Drug Administration, the Federal Trade Commission and other regulatory agencies.
Corey Hilmas, MD, PhD, Senior VP of Scientific and Regulatory Affairs, Natural Products Association: A medical doctor with a degree from the University of Maryland School of Medicine and a doctorate in pharmacology and toxicology, Dr Hilmas joined the NPA after having served as Chief of the Dietary Supplement Regulation Implementation Branch under the Division of Dietary Supplement Programs at the FDA for more than two years. Prior to this he served as Senior Toxicologist for Dietary Ingredients at the FDA, and worked as a physiologist and principal investigator for the US Army Medical Research Institute of Chemical Defense.
Cheryl Kos, ND, Metagenics: Cheryl has lived in Europe, Asia and the US and works in the regulatory group at Metagenics on global product substantiation and new ingredient assessment.
Please click the following link for more information and to register for Inflammation: Opportunities and Challenges.
The event is supported by the following leading nutritional ingredient suppliers:
Soft Gel Technologies, Inc. (SGTI): A full-service contract manufacturer, specializing in providing marketers with premium quality dietary supplements in a soft gelatin capsule delivery system. SGTI is dedicated to the production and marketing of branded products and turnkey custom formulations exclusively to the nutraceutical industry including Sytrinol softgels, which contain a patented blend of polymethoxylated flavones and tocotrienols.
Cyactiv by Cerule: Cerule is a trusted raw material manufacturer and provider of ‘Algaceuticals’, a new category of scientifically researched, high quality, blue-green algae extracts containing bioactive compounds that deliver proven health benefits. By inhibiting COX-2 and Lipoxygenase enzyme activity, reducing prostaglandins, neutralizing free radicals and inhibiting ROS formation, Cyactiv takes a multi-pronged approach to inflammation management.
Sabinsa: A manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries. For the past 25 years, Sabinsa has brought to market more than 100 standardized botanical extracts, several with clinical studies in conjunction with prestigious institutions in support of these products.
Natreon, Inc: A developer of novel compounds extracted from the traditional botanicals of Ayurvedic medicine. The company has created a broad portfolio of products and technologies with compelling intellectual property, including highly purified shilajit (one of the most important Ayurvedic remedies) - PrimaVie, Phyllanthus emblica (the superfruit Indian gooseberry) – Capros, and Withania somnifera (Ashwagandha or Indian ginseng) – Sensoril.
